- Home
- AVIR vs ATGL Comparison
AVIR vs ATGL Comparison
Compare AVIR & ATGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- ATGL
- Stock Information
- Founded
- AVIR 2012
- ATGL 2017
- Country
- AVIR United States
- ATGL Hong Kong
- Employees
- AVIR N/A
- ATGL N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- ATGL
- Sector
- AVIR Health Care
- ATGL
- Exchange
- AVIR Nasdaq
- ATGL Nasdaq
- Market Cap
- AVIR 290.4M
- ATGL 299.1M
- IPO Year
- AVIR 2020
- ATGL 2023
- Fundamental
- Price
- AVIR $2.97
- ATGL $31.28
- Analyst Decision
- AVIR Hold
- ATGL
- Analyst Count
- AVIR 1
- ATGL 0
- Target Price
- AVIR $6.00
- ATGL N/A
- AVG Volume (30 Days)
- AVIR 223.7K
- ATGL 7.6K
- Earning Date
- AVIR 11-06-2025
- ATGL 01-01-0001
- Dividend Yield
- AVIR N/A
- ATGL N/A
- EPS Growth
- AVIR N/A
- ATGL N/A
- EPS
- AVIR N/A
- ATGL N/A
- Revenue
- AVIR N/A
- ATGL $1,590,148.00
- Revenue This Year
- AVIR N/A
- ATGL N/A
- Revenue Next Year
- AVIR N/A
- ATGL N/A
- P/E Ratio
- AVIR N/A
- ATGL N/A
- Revenue Growth
- AVIR N/A
- ATGL 42.17
- 52 Week Low
- AVIR $2.46
- ATGL $1.22
- 52 Week High
- AVIR $4.10
- ATGL $57.32
- Technical
- Relative Strength Index (RSI)
- AVIR 33.48
- ATGL 55.95
- Support Level
- AVIR $2.84
- ATGL $28.00
- Resistance Level
- AVIR $3.33
- ATGL $33.93
- Average True Range (ATR)
- AVIR 0.14
- ATGL 2.27
- MACD
- AVIR -0.04
- ATGL -0.35
- Stochastic Oscillator
- AVIR 18.98
- ATGL 42.36
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About ATGL Alpha Technology Group Limited
Alpha Technology Group Ltd operates through its subsidiaries, which are established cloud-based IT solution service providers in Hong Kong. Its Operating Subsidiaries utilize its analytic skills, programming skills, artificial intelligence technologies and technological know-how to provide comprehensive solutions designed to optimize the business performance of customers, meet various industry-specific operational challenges of customers and create new business opportunities for customers. The Operating Subsidiaries provide services for customers from a variety of industries, including consulting, real estate, architectural design, carpark management, electronic payment services, logistics, investments, retail, textiles, wholesale and distribution, etc.